Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Discover wealth building strategies for retirement at 50. Position yourself for a prosperous and secure retirement.
16,725 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A wave of options activity suggests a bearish tilt for Tesla ahead of its Q2 earnings, with net short delta near $550...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
RPM International just posted a record Q4 EBIT across its segments. Alongside an insider Form 4 filing, this raises q...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
A new Federal Reserve chair is on the horizon, and markets are keen to know what it means for loans, mortgages, and i...
As Pool Corp closes its Q4, investors weigh the implications for pool corp (pool) 2025. This guide breaks down the ea...
Ripple CEO Brad Garlinghouse says the US CLARITY Act is moving toward passage by April, a development that could end ...
Europe’s Société Générale expands its euro stablecoin strategy by deploying EUR CoinVertible on the XRP Ledger, the l...
An executive move at Cirrus Logic involving 3,000 shares draws attention to insider trading signals. This article bre...